Nexalis Therapeutics Limited (ASX:NX1)
Australia · Delayed Price · Currency is AUD 0.0230
-0.0010 (-4.17%)
At close: May 29, 2026
Nexalis Therapeutics Market Cap
Nexalis Therapeutics has a market cap or net worth of 5.82 million as of May 29, 2026. Its market cap has decreased by -38.66% in one year.
Market Cap
5.82M
Enterprise Value
6.12M
Revenue
986.43K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since January 11, 2017, Nexalis Therapeutics's market cap has decreased from 29.98M to 5.82M, a decrease of -80.58%. That is a compound annual growth rate of -16.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.82M | 1.31% |
| Dec 29, 2025 | 5.74M | -23.11% |
| Dec 30, 2024 | 7.47M | 35.76% |
| Dec 18, 2023 | 5.50M | -51.02% |
| Dec 29, 2022 | 11.24M | -25.89% |
| Dec 30, 2021 | 15.16M | 46.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 11.95M |
| Cambium Bio | 11.89M |
| Bio-Gene Technology | 8.54M |
| Invex Therapeutics | 8.27M |
| Vectus Biosystems | 6.76M |
| Tissue Repair | 6.65M |
| Acrux | 6.16M |
| Zelira Therapeutics | 5.95M |